148 related articles for article (PubMed ID: 19615275)
1. [Effects of histone deacetylase inhibitor MS-275 on expression of survivin and NF-kappaB in the human myeloma cell line U266 cells].
Ma J; Zhao M; Yu XD
Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):250-3. PubMed ID: 19615275
[TBL] [Abstract][Full Text] [Related]
2. [MS-275, a histone deacetylase inhibitor, induces apoptosis and alters survivin gene expression in human myeloma cell line U266].
Ma J; Zhao M; Yu XD; Wang ZH
Ai Zheng; 2009 May; 28(5):466-71. PubMed ID: 19624872
[TBL] [Abstract][Full Text] [Related]
3. BAY-11-7082 induces apoptosis of multiple myeloma U266 cells through inhibiting NF-κB pathway.
Wang Y; Zhang XL; Sun CM
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2564-2571. PubMed ID: 29771406
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of JAK1/STAT3 signaling mediates compound K-induced apoptosis in human multiple myeloma U266 cells.
Park S; Lee HJ; Jeong SJ; Song HS; Kim M; Lee HJ; Lee EO; Kim DH; Ahn KS; Kim SH
Food Chem Toxicol; 2011 Jun; 49(6):1367-72. PubMed ID: 21420464
[TBL] [Abstract][Full Text] [Related]
5. [Glycyrrhetinic acid induces apoptosis and alters survivin gene expression in human myeloma cell line U266].
Xu SM; Zhou L; Liu ZG; Chen B; Li Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):652-5. PubMed ID: 21729543
[TBL] [Abstract][Full Text] [Related]
6. [Differentiating effect of PPARgamma ligand rosiglitazone and all trans-retinoic acid on myeloma cells and its possible mechanism].
Huang HW; Chen GH; Chang HR; Chow HC; Leung AY; Liang R; Wu DP
Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):885-9. PubMed ID: 20193324
[TBL] [Abstract][Full Text] [Related]
7. The short-term effect of histone deacetylase inhibitors, chidamide and valproic acid, on the NF‑κB pathway in multiple myeloma cells.
Liu Z; Jing Q; Wang Y; Li Y; Mi F; Xiang C; Fu R
Int J Mol Med; 2019 Jan; 43(1):285-293. PubMed ID: 30387821
[TBL] [Abstract][Full Text] [Related]
8. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors.
Pei XY; Dai Y; Grant S
Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093
[TBL] [Abstract][Full Text] [Related]
9. [Mechanisms of Apoptosis Induced by FTY720 in Multiple Myeloma Cell Line U266].
Liao AJ; Li SC; Wu B; Hu R; Li YC; Yao K; Yang W; Liu ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec; 23(6):1623-7. PubMed ID: 26708883
[TBL] [Abstract][Full Text] [Related]
10. Effects of Histone Deacetylase Inhibitor Panobinostat (LBH589) on Bone Marrow Mononuclear Cells of Relapsed or Refractory Multiple Myeloma Patients and Its Mechanisms.
Ma Y; Liu W; Zhang L; Jia G
Med Sci Monit; 2017 Oct; 23():5150-5157. PubMed ID: 29080899
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide-enhanced, matrine-induced apoptosis in multiple myeloma cell lines.
Yu Q; Chen B; Zhang X; Qian W; Ye B; Zhou Y
Planta Med; 2013 Jun; 79(9):775-81. PubMed ID: 23700110
[TBL] [Abstract][Full Text] [Related]
12. [Effect of trichostatin A and paclitaxel on the growth and apoptosis of lung adenocarcinoma cell lines].
Zhang S; Wang XA; Zhang QC; Jiang SJ
Zhonghua Zhong Liu Za Zhi; 2012 Jul; 34(7):492-6. PubMed ID: 22967465
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 overexpression increases the susceptibility of human U266 myeloma cells to CDK inhibitors through a process involving p130-, p107- and E2F-dependent S phase entry.
Dai Y; Hamm TE; Dent P; Grant S
Cell Cycle; 2006 Feb; 5(4):437-46. PubMed ID: 16479154
[TBL] [Abstract][Full Text] [Related]
14. P53-mediated cell cycle arrest and apoptosis through a caspase-3- independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells.
Cui Q; Yu JH; Wu JN; Tashiro S; Onodera S; Minami M; Ikejima T
Acta Pharmacol Sin; 2007 Jul; 28(7):1057-66. PubMed ID: 17588343
[TBL] [Abstract][Full Text] [Related]
15. [Homoharringtonine combined arsenic trioxide induced apoptosis in human multiple myeloma cell line RPMI 8226: an experimental research].
Zhou XJ; Zhou YH; Chen XH; Qian WB
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):834-9. PubMed ID: 23980369
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effects of (S)-HDAC42, a phenylbutyrate-derived histone deacetylase inhibitor, in multiple myeloma cells.
Bai LY; Omar HA; Chiu CF; Chi ZP; Hu JL; Weng JR
Cancer Chemother Pharmacol; 2011 Aug; 68(2):489-96. PubMed ID: 21072520
[TBL] [Abstract][Full Text] [Related]
17. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
18. Curcumin selectively induces apoptosis in cutaneous T-cell lymphoma cell lines and patients' PBMCs: potential role for STAT-3 and NF-kappaB signaling.
Zhang C; Li B; Zhang X; Hazarika P; Aggarwal BB; Duvic M
J Invest Dermatol; 2010 Aug; 130(8):2110-9. PubMed ID: 20393484
[TBL] [Abstract][Full Text] [Related]
19. [Rosiglitazone and all-trans retinoic acid inhibit human myeloma cell proliferation via apoptosis signaling pathway modulation].
Huang HW; Wu DP; Chen GH; Chang HR; Chow HC; Leung AY; Liang R
Zhonghua Xue Ye Xue Za Zhi; 2009 Apr; 30(4):242-6. PubMed ID: 19731824
[TBL] [Abstract][Full Text] [Related]
20. The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1.
Rosato RR; Almenara JA; Grant S
Cancer Res; 2003 Jul; 63(13):3637-45. PubMed ID: 12839953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
